|
Antibody Name/Symbol |
Antibody Description |
Clones/Alternate Names |
|
α-1-antitrypsin |
alpha 1 antitrypsin |
|
Hepatoid Carcinoma |
|
α-fetoprotein |
alpha 1 fetoprotein |
AFP, Z5A06, Clone C3 |
|
β-catenin |
beta catenin; involved in regulation of cell adhesion and in signal transduction through Wnt pathway |
B-catenin, CLONE 14, E-5, RB-9035Po, 17C2, 5H10 |
Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Germ Cell Tumors, Uterus; Hepatoid Carcinoma; Metastatic Melanoma; Microcystic Stromal Tumor; Sertoli-Leydig Cell Tumor; Yolk Sac Tumor, Vagina |
|
34bE12 |
cytokeratin, high molecular weight (34bE12- CK 1, 5, 10, 14) |
MA-903, CK903, 34βE12 |
Ectopic Prostate |
|
Adipophilin |
|
AP125 |
Extramammary Paget Disease; Sebaceous Carcinoma; Sebaceous Hyperplasia; Squamous Cell Carcinoma, Vulva; Vulvar Intraepithelial Neoplasia |
|
AE1/3 |
mixture of 2 anticytokeratin clones that detect a variety of both high-and low- molecular weight cytokeratins |
AE1/AE3 |
Adult Granulosa Cell Tumor; Benign Müllerian Lesions; Dysgerminoma; Fibroadenoma and Phyllodes Tumor; Gonadoblastoma; Malignant Mesothelioma, Peritoneum; Mesodermal Adenosarcoma; Müllerian Adenosarcoma, Cervix; Secondary Neoplasms, Uterus; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Steroid Cell Tumor, Not Otherwise Specified; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary |
|
AE1/AE3 |
mixture of 2 anticytokeratin clones that detect a variety of both high-and low- molecular weight cytokeratins |
AE1/3 |
Adenomatoid Tumor, Fallopian Tube; Basal Cell Carcinoma; Dysgerminoma; Florid Mesothelial Hyperplasia; Hidradenoma Papilliferum; Intraabdominal Desmoplastic Small Round Cell Tumor; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Mesonephric Adenocarcinoma; Mixed Tumor, Vagina; Neuroendocrine Carcinomas, Corpus; Nongestational Choriocarcinoma; Peritoneal Inclusion Cysts; Primitive Neuroectodermal Tumor, Ovary; Sertoli Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Yolk Sac Tumor, Vagina |
|
AFP |
alpha 1 fetoprotein |
α-fetoprotein, Z5A06, Clone C3 |
Dysgerminoma; Endometrioid Adenocarcinoma, Ovary; Hepatoid Carcinoma; Juvenile Granulosa Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Yolk Sac Tumor, Ovary |
|
ALK1 |
anaplastic lymphoma kinase 1 |
5A4, ALKC |
Leiomyosarcoma |
|
AMACR |
alpha-methylacyl CoA racemase |
13H4, P504S |
Ectopic Prostate; Müllerian Papilloma; Sebaceous Hyperplasia |
|
Androgen receptor |
Dihydrotestosterone receptor; nuclear receptor subfamily 3, group C, member 4 |
AR441, F39.4.1, AR-N20, AR27 |
Adenocarcinoma, Serous, Cervix; Ectopic Prostate; Mesonephric Remnants/Hyperplasia; Trichoepithelioma; Extramammary Paget Disease; Mesonephric Adenocarcinoma |
|
Antichymotrypsin |
alpha 1 antichromotrypsin |
α-1-antichromotrypsin, A1ACT |
Lymphomas and Leukemias of the Lower Genital Tract |
|
Antitrypsin |
alpha 1 antitrypsin |
α-1-antitrypsin, A1AT |
Lymphomas and Leukemias of the Lower Genital Tract |
|
AR |
androgen receptor |
AR441, F39.4.1, AR-N20, AR27 |
Benign and Low-Grade Endometrial Stromal Tumors; Deep Glands and Cysts; Leiomyoma and Variants; Leiomyosarcoma; Müllerian Adenosarcoma, Cervix; Sebaceous Carcinoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors |
|
ARID1a |
AT-rich interactive domain-containing protein 1A |
BAF250a |
Mucinous Borderline Tumor, Endocervical Type |
|
B72.3 |
tumor-associated glycoprotein-72 |
CC49, TAG-72, B72.3, BRST-3 |
Adenomatoid Tumor, Fallopian Tube; Bartholin Gland Carcinoma; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Well-Differentiated Papillary Mesothelioma |
|
BAF250a |
AT-rich interactive domain-containing protein 1A |
ARID1a |
Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary |
|
Bcl-2 |
B-cell lymphoma 2; suppresses apoptosis in a variety of cell systems |
ONCL2, BCL2/100/D5, 124, 124.3 |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Endometrioid; Basal Cell Carcinoma; Cervical Infections; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Mesonephric Remnants/Hyperplasia; Ovarian Lymphomas and Leukemias; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Trichoepithelioma; Tubal and Tuboendometrioid Metaplasia |
|
Bcl-6 |
B-cell CLL/lymphoma 6 |
LN22, GI191E/A8, N-3, PG-B6P, P1F6, 3FR-1 |
Cervical Infections; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias |
|
BER-EP4 |
epithelial cell adhesion molecule |
AUA1, VU-1D9, EPCAM, C10, HEA125 |
Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Basal Cell Carcinoma; Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Trichoepithelioma; Well-Differentiated Papillary Mesothelioma |
|
BP180 |
transmembrane protein of the cutaneous basement membrane that plays an important role in epidermal-dermal adhesion |
|
Herpes Gestationis |
|
BRAF |
serine/threonine-protein kinase Braf/proto-oncogene B-Raf/p94/v-Raf murine sarcoma viral oncogene homolog B1 |
|
Struma Ovarii |
|
BRCA1 |
breast and ovarian cancer susceptibility protein 1 |
MS110 |
Endometrioid Adenocarcinoma, Fallopian Tube |
|
C-erb-B2 |
v-erb-b2 erythroblastic leukemia viral gene protein, human epidermal growth factor receptor 2 |
HER2/neu, NEU, HER-2, NCLCBE1, 10A7, 9G6.10, SP3, 4B5, epidermal growth factor receptor 2, P185, 9G6.20, A0485, C-ERBB-2, CB11, ERBB-2, 3B5, TAB250, HERCEPTEST, E2-4001, HER-2_NEU |
Clear Cell Adenocarcinoma, Corpus |
|
C-Kit |
tyrosine-protein kinase activity |
CD117, C-19 (C-KIT), 104D2, 2E4, C-KIT, A4502, H300, CMA-767 |
Cervical Infections; Disseminated Peritoneal Leiomyomatosis; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; Gonadoblastoma; Large Cell Neuroendocrine Carcinoma; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Malignant Melanoma, Vulva; Mesodermal Adenosarcoma; Müllerian Adenosarcoma, Cervix; Neuroendocrine Carcinomas, Corpus; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Sertoli Cell Tumor; Smooth Muscle Tumors, Ovary; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor |
|
CA125 |
|
OV185:1, CA 125, OC125 |
Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Intraabdominal Desmoplastic Small Round Cell Tumor; Metastatic Breast Carcinoma; Metastatic Colorectal Carcinoma; Serous Borderline Tumor, Ovary; Struma Ovarii |
|
CA15-3 |
epithelial membrane antigen |
EMA, GP1.4, 214D4, MC5, E29, MUC1, LICRLON- M8, BC3, DF3, VU3D1, MUSEII, RD-1, MA695, MA552, PS2P446, 115D8, MUC1, MAM6, CA15.3, MUC01 |
Sebaceous Carcinoma |
|
CA19-9 |
tumor marker, cancer antigen 19-9, or sialylated Lewis A antigen |
1116NS19-9 |
Malignant Mesothelioma, Peritoneum |
|
CAE |
gap junction protein |
CAE1, CX50, CZP1, MP70, GJA8 |
Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias |
|
CAIX |
carbonic anhydrase IX |
CA9, ab1508, M75, NB100-417 |
Secondary Neoplasms, Vagina; Struma Ovarii |
|
Calcitonin |
polypeptide hormone produced by parafollicular cells (C cells) of the thyroid |
CALBINDIN28 |
Carcinoid Tumor (Insular, Trabecular, and Mucinous); Neuroendocrine Tumors; Transitional Cell Metaplasia |
|
Caldesmon |
actin interacting and calmodulin binding protein found in smooth muscle and other cell types |
|
Benign and Low-Grade Endometrial Stromal Tumors; Clear Cell Adenocarcinoma, Corpus; Granular Cell Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyosarcoma; Malignant Melanoma, Vagina; Malignant Mesothelioma, Peritoneum; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Squamous Cell Carcinoma, Vagina; Thecoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors |
|
Calponin |
thin filament-associated protein that is implicated in regulation and modulation of smooth muscle contraction |
N3, 26A11, CALP, CNN1, SMCC, Sm Calp |
Fibroadenoma and Phyllodes Tumor; Hidradenoma Papilliferum; Inflammatory Myofibroblastic Tumor; Mixed Tumor, Vulva |
|
Calretinin |
29 kDa calcium binding protein that is expressed in central and peripheral nervous system and in many normal and pathological tissues |
DAK-CALRET, 5A5, CAL 3F5, DC8, AB149 |
Adenocarcinoma, Serous, Cervix; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Benign Brenner Tumor; Dysgerminoma; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometriosis and Deciduosis; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Follicular Cysts; Gonadoblastoma; Hepatoid Carcinoma; High-Grade Serous Adenocarcinoma; Juvenile Granulosa Cell Tumor; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Melanoma; Microcystic Stromal Tumor; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Sclerosing Stromal Tumor; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Sex Cord-Stromal Tumor, Not Otherwise Specified; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Steroid Cell Tumor, Not Otherwise Specified; Stromal Hyperplasia and Hyperthecosis; Stromal Luteoma; Struma Ovarii; Strumal Carcinoid; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary |
|
CAM 5.2 |
cytokeratin 8/18 (CAM5.2) |
5D3, Zym5.2, 5D3, CAM 5.2, KER 10.11, NCL-5D3 |
Adenoid Basal Carcinoma; Adenomatoid Tumor, Fallopian Tube; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Bartholin Gland Carcinoma; Basal Cell Carcinoma; Extramammary Paget Disease; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Melanoma, Vulva; Malignant Mesothelioma, Peritoneum; Mesonephric Adenocarcinoma; Müllerian Papilloma; Neuroendocrine Carcinomas, Corpus; Rhabdomyosarcoma, Corpus; Sebaceous Carcinoma; Sertoli Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified |
|
Carbonic anhydrase IX |
|
CAIX, CA9, ab1508, M75, NB100-417 |
Alveolar Soft Part Sarcoma |
|
Carcinoembryonic antigen |
carcinoembryonic antigen |
CEA-M, mCEA, CEA-B18, CEA-D14, CEAGOLD 1, T84.6, CEA-GOLD 2, CEA 11, CEA-GOLD 3, CEA 27, CEAGOLD 4, CEA 41, CEA-GOLD 5, T84.1, CEA-M, A5B7, CEJ065, IL-7, T84.66, TF3H8-1, 0062, D14, alpha-7, PARLAM 1, ZC23, CEM010, A115, COL-1, AF4, 12.140.10, 11-7, M773, CEA-M431_31, CEJO65 |
Mucinous Adenocarcinoma, Corpus |
|
CD1a |
T-cell surface glycoprotein expressed in Langerhans cells as well as in leukemias |
JPM30, CD1A, O10, NA1/34 |
Lymphomas and Leukemias of the Lower Genital Tract; Perivascular Epithelioid Cell (PEC) Proliferations |
|
CD3 |
T-cell receptor |
F7238, A0452, CD3-P, CD3-M, SP7, PS1 |
Inflammatory Myofibroblastic Tumor; Ovarian Lymphomas and Leukemias |
|
CD4 |
T-cell surface glycoprotein L3T4 |
IF6, 1290, 4B12, 1F6, CD04 |
Chancroid; Fixed Drug Eruption; Inflammatory Myofibroblastic Tumor; Squamous Cell Carcinoma, Cervix |
|
CD5 |
T-cell surface glycoprotein Leu1, T1 |
NCL-CD5, 4C7, 54/B4, 54/F6 |
Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias; Undifferentiated Carcinoma, Corpus |
|
CD8 |
T-cell coreceptor antigen, Leu 2, Tcytotoxic cells |
M7103, C8/144, C8/144B |
Fixed Drug Eruption; Inflammatory Myofibroblastic Tumor |
|
CD9 |
motility-related protein-1 (MRP-1) |
72F16, BA-2 |
Primitive Neuroectodermal Tumor, Peripheral and Central Types |
|
CD10 |
neutral endopeptidase; germinal center marker positive that is also implicated in lymphoblastic leukemias |
NCL-270, CALLA, neprilysin, NEP |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Basal Cell Carcinoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Cervical Infections; Deciduosis; Deep Glands and Cysts; Ectopic Prostate; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid-Type Adenomyoma; Endometriosis and Deciduosis; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Gastric Carcinoma; Microcystic Stromal Tumor; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Nongestational Choriocarcinoma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Ovarian Lymphomas and Leukemias; Perivascular Epithelioid Cell (PEC) Proliferations; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Pseudomyxoma Peritonei; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Sebaceous Carcinoma; Secondary Neoplasms, Vagina; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Struma Ovarii; Thecoma; Trichoepithelioma; Tubal and Tuboendometrioid Metaplasia; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Vaginal Cysts; Wilms Tumor |
|
CD13 |
plays role in growth of DC/macrophage progenitors and precursors |
|
Lymphomas and Leukemias of the Lower Genital Tract |
|
CD14 |
coreceptor for lipopolysaccharide binding protein |
FMC32 |
Lymphomas and Leukemias of the Lower Genital Tract |
|
CD15 |
reacts with Reed-Sternberg cells of Hodgkin disease and with granulocytes |
VIM-2, 3C4, LEU-M1, TU9, VIM-D5, MY1, CBD1, MMA, 3CD1, C3D1, Lewis x, SSEA-1 |
Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Mesothelioma, Peritoneum; Sebaceous Carcinoma |
|
CD19 |
B-cell antigen |
|
Lymphoma and Leukemia, Uterus |
|
CD20 |
B-lymphocyte antigen CD20/leukocyte surface antigen Leu-16 |
FB1, B1, L26, MS4A1 |
Cervical Infections; Inflammatory Myofibroblastic Tumor; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Undifferentiated Carcinoma, Corpus |
|
CD23 |
Fc ε RII, low-affinity IgE receptor, IGEBF |
1B12, MHM6BU38 |
Lymphoma and Leukemia, Uterus |
|
CD25 |
If-2 receptor alpha |
2A3, 4C9 |
Fixed Drug Eruption |
|
CD30 |
tumor necrosis factor SF8 |
BER-H2, KI-1, TNFRSF8 |
Dysgerminoma; Inflammatory Myofibroblastic Tumor; Lymphomas and Leukemias of the Lower Genital Tract |
|
CD31 |
platelet endothelial cell adhesion molecule |
JC/70, JC/70A, PECAM-1 |
Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Peritoneal Inclusion Cysts; Squamous Cell Carcinoma, Vulva |
|
CD34 |
hematopoietic progenitor cell antigen |
MY10, IOM34, QBEND10, 8G12, 1309, HPCA-1, NU-4A1, TUK4, clone 581, BI-3c5 |
Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Basal Cell Carcinoma; Cellular Angiofibroma; Cervical Infections; Deep Aggressive Angiomyxoma; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Epithelioid Sarcoma; Extragastrointestinal Stromal Tumor; Fibroadenoma and Phyllodes Tumor; Fibromatous Neoplasms; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Luteinized Thecoma With Sclerosing Peritonitis; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Mesothelioma, Peritoneum; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Ovarian Involvement by Gastrointestinal Stromal Tumor; Perivascular Epithelioid Cell (PEC) Proliferations; Prepubertal Vulval Fibroma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Squamous Cell Carcinoma, Vulva; Superficial Angiomyxoma; Trichoepithelioma |
|
CD43 |
major sialoglycoprotein on surface of human T lymphocytes, monocytes, granulocytes, and some B lymphocytes |
LEU-22, DF-T1, L60, MT1, sialophorin, leukosialin, SPN |
Cervical Infections; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Neuroendocrine Tumors; Ovarian Lymphomas and Leukemias |
|
CD45 |
leukocyte common antigen |
LCA, PD7/26, 1.22/4.14, T29/33, RP2/18, PD7, 2D1, 2B11+PD7/26 |
Adult Granulosa Cell Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Lymphomas and Leukemias; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Undifferentiated Carcinoma, Corpus |
|
CD56 |
neutral cellular adhesion molecule |
MAB735, ERIC-1, 25-KD11, 123C3, 24-MB2, BC56C04, 1B6, 14-MAB735, NCC-LU-243, MOC-1, NCAM |
Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endometrioid Adenocarcinoma, Ovary; Endometriosis and Deciduosis; Fibromatous Neoplasms; Gonadoblastoma; Immature Teratoma; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Corpus; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Thecoma; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Undifferentiated Carcinoma, Corpus; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor |
|
CD57 |
β-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
LEU-7, NK1, HNK-1, TB01, B3GAT1 |
Intraabdominal Desmoplastic Small Round Cell Tumor |
|
CD68 |
cytoplasmic granule protein of monocytes, macrophages |
PG-M1, KP-1 |
Cervical Infections; Deciduosis; Epithelioid Sarcoma; Granular Cell Tumor; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Mucinous Cystic Tumor with Mural Nodules; Ovarian Lymphomas and Leukemias; Verruciform Xanthoma |
|
CD79a |
immunoglobulin-associated alpha, MB1 |
MB-1, 11D10, 11E3, CD79A, HM47/A9, HM57, JCB117, CD79a, CD79-α |
Lymphomas and Leukemias of the Lower Genital Tract; Lymphoma and Leukemia, Uterus |
|
CD99 |
cell surface glycoprotein for migration, T cell adhesion, MIC2 |
CD99-MEMB, MIC2, 12E7, HBA71, O13, P30/32MIC2, M3601 |
Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Endometrioid Adenocarcinoma, Ovary; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Leydig Cell Tumor; Malignant Mixed Mesodermal Tumor; Mixed Tumor, Vagina; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor |
|
CD117 |
C-kit, tyrosine-protein kinase activity |
C-19 (C-KIT), 104D2, 2E4, C-KIT, A4502, H300, CMA-767 |
Dysgerminoma; Extragastrointestinal Stromal Tumor; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Lymphomas and Leukemias of the Lower Genital Tract; Ovarian Involvement by Gastrointestinal Stromal Tumor; Perivascular Epithelioid Cell (PEC) Proliferations; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Secondary Neoplasms, Vagina; Solitary Fibrous Tumor, Peritoneum; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Yolk Sac Tumor, Ovary |
|
CD138 |
syndecan; a useful marker for plasma cells |
B-B4, AM411-10M, MI15 |
Endometritis |
|
CD146 |
melanoma cell adhesion molecule |
MCAM |
Deciduosis |
|
CDX-2 |
caudal-type homeobox transcription factor 2 |
AMT28, 7C7/D4, CDX-2-88 |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell; Carcinoma; Benign Brenner Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endocervicosis; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Extramammary Paget Disease; Metastatic Appendiceal Tumors; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Metastatic/Secondary Tumors to the Cervix; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Pseudomyxoma Peritonei; Secondary Neoplasms, Uterus; Secondary Neoplasms, Vagina; Strumal Carcinoid |
|
CEA |
carcinoembryonic antigen |
mCEA, CEA-B18, CEA-D14, CEAGOLD 1, T84.6, CEA-GOLD 2, CEA 11, CEA-GOLD 3, CEA 27, CEAGOLD 4, CEA 41, CEA-GOLD 5, T84.1, CEA-M, A5B7, CEJ065, IL-7, T84.66, TF3H8-1, 0062, D14, alpha-7, PARLAM 1, ZC23, CEM010, A115, COL-1, AF4, 12.140.10, 11-7, M773, CEA-M431_31, CEJO65 |
Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenocarcinoma, Villoglandular; Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Adenomatoid Tumor, Corpus; Adenosquamous Carcinoma Including Glassy Cell Carcinoma; Bartholin Gland Carcinoma; Eccrine Spiradenoma; Endocervical-Type Adenomyoma; Endometrial Metaplasias; Extramammary Paget Disease; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Ovary; Mesonephric Adenocarcinoma; Microcystic Adnexal Carcinoma; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Müllerian Papilloma; Neuroendocrine Tumors; Peritoneal Inclusion Cysts; Syringoma |
|
Chromogranin |
pituitary secretory protein 1 |
Chromogranin A, PHE-5, PHE5, E001, DAK-A3 |
Adult Granulosa Cell Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Lung Carcinoma; Neuroendocrine Carcinomas, Corpus; Primitive Neuroectodermal Tumor, Ovary; Rhabdomyosarcoma, Corpus; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Strumal Carcinoid |
|
Chromogranin A |
pituitary secretory protein 1 |
PHE-5, PHE5, E001, DAK-A3 |
Adenocarcinoma, Minimal Deviation |
|
CK1 |
cytokeratin 1 |
CK 01, 34BB4 |
Mesonephric Adenocarcinoma |
|
CK5 |
cytokeratin 5 |
XM26, RCK103, 34BEH12 |
Adenomatoid Tumor, Fallopian Tube; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Microcystic Adnexal Carcinoma; Peritoneal Inclusion Cysts; Syringoma; Trichoepithelioma |
|
CK5/6 |
cytokeratin 5/6, high molecular weight cytokeratins |
D5/16 B4 |
Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Benign Müllerian Lesions; Florid Mesothelial Hyperplasia; Hidradenoma Papilliferum; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Squamous Cell Carcinoma, Vagina |
|
CK7 |
cytokeratin 7, low molecular weight cytokeratin |
K72.7, KS7.18, OVTL 12/30, LDS-68, CK 07 |
Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell; Carcinoma; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Benign Brenner Tumor; Benign Müllerian Lesions; Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Clear Cell Carcinoma, Vagina; Eccrine Spiradenoma; Endocervicosis; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Endometriosis and Deciduosis; Extramammary Paget Disease; Female Adnexal Tumor of Probable Wolffian Origin; Fibroadenoma and Phyllodes Tumor; Hepatoid Carcinoma; Hidradenoma Papilliferum; Large Cell Neuroendocrine Carcinoma; Malignant Brenner Tumor; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Cervical Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Microcystic Adnexal Carcinoma; Mixed Tumor, Vagina; Mixed Tumor, Vulva; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Neuroendocrine Carcinomas, Corpus; Proliferating/Borderline Brenner Tumor; Pseudomyxoma Peritonei; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Signet Ring Cell Stromal Tumor; Squamous Cell Carcinoma, Cervix; Strumal Carcinoid; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Vaginal Intraepithelial Neoplasia; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina |
|
CK13 |
cytokeratin 13 |
KS13.1, KS-1A3, AE8, 2D7 |
Transitional Cell Metaplasia |
|
CK14 |
cytokeratin 14, high molecular weight cytokeratin |
LL002 |
Microcystic Adnexal Carcinoma |
|
CK15 |
cytokeratin 15 |
LHK15 |
Basal Cell Carcinoma; Trichoepithelioma; Trichofolliculoma |
|
CK17 |
cytokeratin 17 |
E3 |
Microcystic Adnexal Carcinoma; Mucinous Borderline Tumor, Endocervical Type; Transitional Cell Metaplasia |
|
CK18 |
cytokeratin 18 |
M9, DC-10, CY-90, KS18.04 |
Adenomatoid Tumor, Fallopian Tube; Hepatoid Carcinoma; Leiomyosarcoma; Squamous Cell Carcinoma, Cervix; Transitional Cell Metaplasia; Trichoepithelioma; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma |
|
CK19 |
cytokeratin 19, low molecular weight cytokeratin |
BA17, RCK108, LP2K, B170, A53-BA2, KS19.1, 170.2.14 |
Hepatoid Carcinoma; Sebaceous Carcinoma |
|
CK20 |
cytokeratin 20, low molecular weight cytokeratin |
KS20.8 |
Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell; Carcinoma; Basal Cell Carcinoma; Benign Brenner Tumor; Dysgerminoma; Endocervicosis; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Extramammary Paget Disease; Female Adnexal Tumor of Probable Wolffian Origin; Hepatoid Carcinoma; Large Cell Neuroendocrine Carcinoma; Malignant Brenner Tumor; Malignant Melanoma, Vulva; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Cervical Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Metastatic/Secondary Tumors to the Cervix; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Müllerian Papilloma; Proliferating/Borderline Brenner Tumor; Pseudomyxoma Peritonei; Secondary Neoplasms, Uterus; Secondary Neoplasms, Vagina; Serous Carcinoma, Peritoneum; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Squamous Cell Carcinoma, Vagina; Strumal Carcinoid; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Transitional Cell Metaplasia; Yolk Sac Tumor, Vagina |
|
CK903 |
cytokeratin-HMW, not otherwise specified |
CK-HMW-NOS, CK-HMW, HMWCK, 34bE12 |
Basal Cell Carcinoma; Sebaceous Carcinoma; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva |
|
CK-PAN |
cytokeratin-pan (AE1/AE3/LP34); cocktail of high and low molecular weight cytokeratins |
keratin pan, MAK-6, K576, LU-5, KL-1, KC-8, MNF 116, pankeratin, pancytokeratin |
Benign and Low-Grade Endometrial Stromal Tumors; Squamous Cell Carcinoma, Vulva |
|
Claudin-4 |
|
3E2C1 |
High-Grade Serous Adenocarcinoma; Malignant Mesothelioma, Peritoneum; Serous Carcinoma, Peritoneum |
|
CMV |
cytomegalovirus |
|
Cervical Infections; Endometritis |
|
Collagen IV |
major constituent of the basement membranes along with laminins, proteoglycans, and enactins |
CIV22, COL4A [1-5], collagen α-1(IV) chain |
Bartholin Gland Carcinoma |
|
Cyclin-D1 |
protein with important cell cycle regulatory functions |
bcl-1 (cyclin D1) A-12, PRAD1, AM29, DCS-6, SP4, 5D4, D1GM, P2D11F11, CCND1Cyl-1 |
Clear Cell Adenocarcinoma, Corpus; Extragastrointestinal Stromal Tumor; High-Grade Endometrial Stromal Sarcoma; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Transitional Cell Carcinoma (Non-Brenner Type); Undifferentiated Uterine Sarcoma |
|
Cytokeratin |
|
|
Adenocarcinoma, Intestinal Including Gastric and Signet Ring Cell; Alveolar Soft Part Sarcoma; Deciduosis; Endometrioid Adenocarcinoma and Variants, Corpus; Epithelioid Sarcoma; Female Adnexal Tumor of Probable Wolffian Origin; Large Cell Neuroendocrine Carcinoma; Leiomyosarcoma; Malignant Mixed Müllerian Tumor, Cervix; Metaplastic Papillary Tumor; Metastatic Pancreaticobiliary Adenocarcinoma; Microcystic Adnexal Carcinoma; Microcystic Stromal Tumor; Mixed Tumor, Vulva; Mucinous Adenocarcinoma, Ovary; Mucinous Cystic Tumor with Mural Nodules; Neuroendocrine Tumors; Perivascular Epithelioid Cell (PEC) Proliferations; Rhabdomyosarcoma, Cervix; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Vulva; Well-Differentiated Papillary Mesothelioma; Stromal Luteoma |
|
Cytokeratin 5 |
|
|
Epithelioid Sarcoma; Intraabdominal Desmoplastic Small Round Cell Tumor |
|
Cytokeratin 5/6 |
cytokeratin 5/6, high molecular weight cytokeratins |
D5/16 B4 |
Squamous Cell Carcinoma, Vulva; Epithelioid Sarcoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Serous Borderline Tumor, Peritoneum; Squamous Cell Carcinoma, Vulva; Well-Differentiated Papillary Mesothelioma |
|
Cytokeratin 6 |
|
CK6, LL020, LHK6B, CK 06 |
Epithelioid Sarcoma |
|
Cytokeratin 7 |
cytokeratin 7, low molecular weight cytokeratin |
K72.7, KS7.18, OVTL 12/30, LDS-68, CK 07 |
Adenoid Basal Carcinoma; Alveolar Soft Part Sarcoma; Metastatic Pancreaticobiliary Adenocarcinoma; Well-Differentiated Papillary Mesothelioma |
|
Cytokeratin 18 |
cytokeratin 18 |
M9, DC-10, CY-90, KS18.04 |
Malignant Mixed Müllerian Tumor, Corpus |
|
Cytokeratin 20 |
cytokeratin 20, low molecular weight cytokeratin |
KS20.8 |
Intraabdominal Desmoplastic Small Round Cell Tumor; Metastatic Pancreaticobiliary Adenocarcinoma; Mucinous Adenocarcinoma, Ovary |
|
D2-40 |
reacts with an O-linked sialoglycoprotein found on lymphatic endothelium |
podoplanin, M2A, D2-40 |
Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Basal Cell Carcinoma; Benign Müllerian Lesions; Dysgerminoma; Eccrine Spiradenoma; Endometriosis and Deciduosis; Extramammary Paget Disease; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Microcystic Adnexal Carcinoma; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Trichoepithelioma; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary |
|
Desmin |
class III intermediate filaments found in muscle cells |
M760, DE-R-11, D33, DE5, DE-U-10, ZC18 |
Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Cellular Angiofibroma; Clear Cell Adenocarcinoma, Corpus; Deep Aggressive Angiomyxoma; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Endocervical-Type Adenomyoma; Extragastrointestinal Stromal Tumor; Fibroepithelial Stromal Polyp; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Granular Cell Tumor; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Intravenous Leiomyomatosis; Juvenile Granulosa Cell Tumor; Leiomyoma and Variants; Leiomyosarcoma; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Massive Vulval Edema; Mesodermal Adenosarcoma; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Müllerian Papilloma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Polyps; Prepubertal Vulval Fibroma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Superficial Angiomyxoma; Thecoma; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor; Yolk Sac Tumor, Vagina |
|
DOG1 |
transmembrane protein 16A |
DOG1 (TMEM16A), DOG 1.1 |
Disseminated Peritoneal Leiomyomatosis; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Mesodermal Adenosarcoma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Ovarian Involvement by Gastrointestinal Stromal Tumor; Secondary Neoplasms, Vagina; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum |
|
E-cadherin |
epithelial calcium dependent adhesion molecule |
36B5, ECH-6, ECCD-2, CDH1, 5H9, NCH 38, Clone 36, 4A2 C7, E9, 67A4, HECD-1, SC-8426 |
Clear Cell Adenocarcinoma, Corpus; High-Grade Serous Adenocarcinoma; Malignant Mixed Müllerian Tumor, Corpus |
|
EBER |
Epstein-Barr virus encoded RNA |
|
Cervical Infections |
|
EGFR |
v-erb b1 erythroblastic leukemia viral gene, epidermal growth factor receptor |
2-18C9, EGFR1, EGFR PHRMDX, NCLR1, H11, C-ERBB-1, E30, EGFR. 113, 31G73C6, 2-18C9 |
Transitional Cell Carcinoma (Non-Brenner Type) |
|
EMA |
epithelial membrane antigen |
GP1.4, 214D4, MC5, E29, MUC1, EMA/MUC1 |
Adenocarcinoma, Endometrioid, Cervix; Adenoid Cystic Carcinoma; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Bartholin Gland Carcinoma; Benign Brenner Tumor; Benign Müllerian Lesions; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Clear Cell Carcinoma, Vagina; Deciduosis; Dysgerminoma; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Epithelioid Sarcoma; Extramammary Paget Disease; Female Adnexal Tumor of Probable Wolffian Origin; Florid Mesothelial Hyperplasia; Germ Cell Tumors, Uterus; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Intravenous Leiomyomatosis; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Large Solitary Luteinized Follicle Cyst of Pregnancy; Leiomyoma and Variants; Leiomyosarcoma; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Melanoma, Vulva; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metaplastic Papillary Tumor; Metastatic Appendiceal Tumors; Metastatic Melanoma; Microcystic Adnexal Carcinoma; Microcystic Stromal Tumor; Mixed Tumor, Vagina; Mixed Tumor, Vulva; Müllerian Papilloma; Neuroendocrine Tumors; Nongestational Choriocarcinoma; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Proliferating/Borderline Brenner Tumor; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Sebaceous Carcinoma; Sebaceous Hyperplasia; Serous Carcinoma (Including STIC); Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Sex Cord-Stromal Tumor, Not Otherwise Specified; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Syringoma; Thecoma; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina |
|
Epithelial membrane antigen |
|
EMA, GP1.4, 214D4, MC5, E29, MUC1, EMA/MUC1 |
Endometrioid Adenocarcinoma and Variants, Corpus; Intraabdominal Desmoplastic Small Round Cell Tumor; Smooth Muscle Tumors, Vulva |
|
ER |
estrogen receptor protein |
ERP, 1D5, 6F11, SP1, 15D, H222, TE111, ERP, ER1D5, NCLER611, NCL-ER-LH2, PGP-1A6 |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Deep Aggressive Angiomyxoma; Disseminated Peritoneal Leiomyomatosis; Endocervicosis; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Endometriosis and Deciduosis; Endometriosis, Cervix; Extragastrointestinal Stromal Tumor; Extramammary Paget Disease; Fibroadenoma and Phyllodes Tumor; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Hepatoid Carcinoma; Hidradenoma Papilliferum; High-Grade Endometrial Stromal Sarcoma; High-Grade Serous Adenocarcinoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Low-Grade Serous Adenocarcinoma; Luteinized Thecoma With Sclerosing Peritonitis; Lymphoma and Leukemia, Uterus; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Metastatic Breast Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Uterine Corpus Carcinoma to Ovary; Metastatic/Secondary Tumors to the Cervix; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Polyps; Proliferating/Borderline Brenner Tumor; Rhabdomyoma; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Secondary Neoplasms, Uterus; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Corpus; Stromal Luteoma; Syringoma; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Tubal and Tuboendometrioid Metaplasia; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor; Yolk Sac Tumor, Vagina |
|
ERG |
|
|
Squamous Cell Carcinoma, Vulva |
|
Estrogen receptor |
|
ER, ERP, 1D5, 6F11, SP1, 15D, H222, TE111, ERP, ER1D5, NCLER611, NCLER-LH2, PGP-1A6 |
Fibroepithelial Stromal Polyp; Polyps; Prepubertal Vulval Fibroma |
|
Factor VIII |
factor VIII-related antigen |
FVIIIRAg, F8/86, von Willenbrand factor |
Adenomatoid Tumor, Corpus |
|
Fascin |
marker for Reed-Sternberg cells of Hodgkin disease |
55K2 |
Metastatic Pancreaticobiliary Adenocarcinoma |
|
Fibrin |
mouse IgG Ab against β chain of fibrin that recognizes both murine and human fibrin |
|
Endometrioid Adenocarcinoma and Variants, Corpus; Florid Mesothelial Hyperplasia; Perivascular Epithelioid Cell (PEC) Proliferations; Squamous Cell Carcinoma, Cervix |
|
FLI-1 |
Friend leukemia virus integration 1 |
EWSR2, GI146-222, SC356, FLK-1, FLT-1 |
Benign and Low-Grade Endometrial Stromal Tumors; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mixed Mesodermal Tumor; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Wilms Tumor |
|
FOXL2 |
|
|
Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Fibromatous Neoplasms; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Proliferating/Borderline Brenner Tumor; Serous Borderline Tumor, Ovary; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type) |
|
FSH |
follicle stimulating hormone |
|
Autoimmune Oophoritis |
|
Galectin-3 |
|
NCL-GAL3, B2C10, 9C4 |
Struma Ovarii |
|
GATA3 |
endothelial transcription factor 3 |
|
Adenocarcinoma, Usual Type; Deep Glands and Cysts; Endometrioid Adenocarcinoma, Ovary; Female Adnexal Tumor of Probable Wolffian Origin; Lymphoma and Leukemia, Uterus; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Proliferating/Borderline Brenner Tumor; Sclerosing Stromal Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Squamous Cell Carcinoma, Vagina; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube |
|
GCDFP-15 |
gross cystic disease fluid protein 15 |
SABP, GPIP4, Gp17, 23A3, BRST-2, D6 |
Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Extramammary Paget Disease; Hidradenoma Papilliferum; Leiomyosarcoma; Lymphoma and Leukemia, Uterus; Malignant Melanoma, Vulva; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Microcystic Adnexal Carcinoma; Sclerosing Stromal Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma (Including STIC); Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia |
|
GFAP |
intermediate filament expressed by numerous cells of the CNS |
6F2, M761, GA-51, GFP-8A |
Benign and Low-Grade Endometrial Stromal Tumors; Granular Cell Tumor; Immature Teratoma; Malignant Mixed Mesodermal Tumor; Neuroendocrine Carcinomas, Corpus; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Wilms Tumor |
|
Glucagon |
hormone secreted by the pancreas; functions to increase blood glucose levels |
|
Neuroendocrine Tumors |
|
Glypican-3 |
heparan sulfate proteoglycan with elevated expression in hepatocellular carcinoma |
1G12, GPC3 |
Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Dysgerminoma; Endometrioid Adenocarcinoma, Ovary; Germ Cell Tumors, Uterus; Metastatic Melanoma; Microcystic Stromal Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina |
|
Gross cystic fluid protein 15 |
|
GCDFP-15, SABP, GPIP4, Gp17, 23A3, BRST-2, D6 |
Metastatic/Secondary Tumors to the Cervix |
|
H-caldesmon |
|
High molecular weight caldesmon, H-CD |
Adenomatoid Tumor, Fallopian Tube; Alveolar Soft Part Sarcoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Endocervical Polyp; Endocervical-Type Adenomyoma; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; High-Grade Endometrial Stromal Sarcoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Malignant Melanoma, Vulva; Ovarian Involvement by Gastrointestinal Stromal Tumor; Peritoneal Inclusion Cysts; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Vulva; Undifferentiated Uterine Sarcoma |
|
HBME-1 |
mesothelioma antibody |
|
Adenomatoid Tumor, Corpus; Malignant Mesothelioma, Peritoneum; Struma Ovarii |
|
HCG |
human chorionic gonadotropin |
|
Dysgerminoma; Leiomyosarcoma; Nongestational Choriocarcinoma |
|
HCG-β |
human chorionic gonadotropin beta subunit |
|
Endometrioid Adenocarcinoma and Variants, Corpus |
|
Hep-Par1 |
hepatocyte paraffin 1 |
OCH1E5.2.10, HEPPAR1 |
Hepatoid Carcinoma; Yolk Sac Tumor, Ovary |
|
Hepatocyte nuclear factor |
|
HNF-1-α, HNF-1-β |
Clear Cell Adenocarcinoma, Corpus; Microglandular Hyperplasia |
|
HER2 |
v-erb-b2 erythroblastic leukemia viral gene protein, human epidermal growth factor receptor 2 |
c-erb-B2, HER2/neu, NEU, HER-2, NCL-CBE1, 10A7, 9G6.10, SP3, 4B5, epidermal growth factor receptor 2, P185, 9G6.20, A0485, C-ERBB-2, CB11, ERBB-2, 3B5, TAB250, HERCEPTEST, E2-4001, HER-2_NEU |
Extramammary Paget Disease; Mucinous Adenocarcinoma, Ovary; Serous Adenocarcinoma, Corpus |
|
HIK1083 |
|
|
Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinomas, Non-Clear Cell Type; Deep Glands and Cysts; Endocervical Glandular Hyperplasia (Diffuse and Lobular); Endocervical-Type Adenomyoma; Tunnel Clusters |
|
Histone deacetylase 8 |
|
HDAC8, T-19 |
Uterine Tumors Resembling Ovarian Sex Cord Tumors |
|
HLA-G |
human leukocyte antigen G |
4H84 |
Squamous Intraepithelial Lesion/Dysplasia |
|
HMB-45 |
antigen present in melanocytic tumors such as melanomas |
LB39 AA, CMM1, CMM, DNS, FAMMM, MART-1, Melan-A, MLM, tyrosinase |
Adenocarcinoma, Clear Cell, Cervix; Alveolar Soft Part Sarcoma; Atypical Nevus of the Genital Tract; Clear Cell Adenocarcinoma, Corpus; Dermatofibrosarcoma Protuberans; Disseminated Peritoneal Leiomyomatosis; Dysgerminoma; Epithelioid Sarcoma; Extramammary Paget Disease; Hepatoid Carcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyoma and Variants; Leiomyosarcoma; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Mucosal Melanotic Macule; Perivascular Epithelioid Cell (PEC) Proliferations; Secondary Neoplasms, Uterus; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Struma Ovarii; Leiomyoma and Variants; Serous Adenocarcinoma, Corpus; Solitary Fibrous Tumor, Vulva |
|
HMGA2 |
high mobility group chromatin protein A2 |
|
Leiomyoma and Variants; Serous Adenocarcinoma, Corpus; Solitary Fibrous Tumor, Vulva |
|
HNF-1 |
hepatocyte nuclear factor |
|
Struma Ovarii |
|
HNF-1-α |
hepatocyte nuclear factor 1 alpha |
|
Struma Ovarii |
|
HNF-1-β |
hepatocyte nuclear factor 1 beta |
|
Adenocarcinoma, Clear Cell, Cervix; Borderline Clear Cell Adenofibroma; Dysgerminoma; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; High-Grade Serous Adenocarcinoma; Juvenile Granulosa Cell Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Mesonephric Adenocarcinoma; Microglandular Hyperplasia; Secondary Neoplasms, Vagina; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Ovary; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Squamous Cell Carcinoma, Cervix; Stromal Luteoma; Yolk Sac Tumor, Ovary |
|
HPL |
human placental lactogen |
|
Clear Cell Adenocarcinoma, Corpus; Nongestational Choriocarcinoma; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Corpus |
|
HPV |
human papillomavirus |
|
Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Cervical Infections; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Melanoma, Vulva; Malignant Mixed Müllerian Tumor, Cervix; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Cervical Carcinoma; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Ovary; Neuroendocrine Carcinomas, Corpus; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Corpus; Transitional Cell Metaplasia; Vulvar Intraepithelial Neoplasia |
|
HPV 18 |
human papillomavirus 18 |
|
Adenosquamous Carcinoma Including Glassy Cell Carcinoma |
|
HSV |
herpes simplex virus |
|
Endometritis |
|
HSV1 |
herpes simplex virus 1 |
|
Cervical Infections; Herpes Simplex Virus |
|
HSV2 |
herpes simplex virus 2 |
|
Cervical Infections; Herpes Simplex Virus |
|
Human placental lactogen |
|
HPL |
Perivascular Epithelioid Cell (PEC) Proliferations |
|
IL-15 |
interleukin 15 |
|
Fixed Drug Eruption |
|
IMP2 |
|
|
Serous Adenocarcinoma, Corpus |
|
IMP3 |
IMP3 protein homolog |
|
Serous Adenocarcinoma, Corpus |
|
Inhibin |
hormone released from testes or ovaries that down-regulates FSH synthesis and secretion |
R1, beta A subunit, INHIBIN |
Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Benign Brenner Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Clear Cell Adenocarcinoma, Corpus; Deciduosis; Dysgerminoma; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Follicular Cysts; Gonadoblastoma; Hepatoid Carcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Large Solitary Luteinized Follicle Cyst of Pregnancy; Leiomyoma and Variants; Leiomyosarcoma; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Melanoma; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Melanoma; Microcystic Stromal Tumor; Müllerian Adenosarcoma, Cervix; Nongestational Choriocarcinoma; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Perivascular Epithelioid Cell (PEC) Proliferations; Proliferating/Borderline Brenner Tumor; Sclerosing Stromal Tumor; Serous Borderline Tumor, Ovary; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Sex Cord-Stromal Tumor, Not Otherwise Specified; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Corpus; Squamous Intraepithelial Lesion/Dysplasia; Steroid Cell Tumor, Not Otherwise Specified; Stromal Hyperplasia and Hyperthecosis; Stromal Luteoma; Struma Ovarii; Strumal Carcinoid; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Yolk Sac Tumor, Ovary |
|
Inhibin-α |
produced by ovarina granulosa cells; inhibits production or secretion of pituitary gonadotropins, a sensitive marker for majority of sex cord-stromal tumors |
|
Benign Müllerian Lesions |
|
INI1 |
member of SWI/SNF chromatin remodeling complex |
BAF47/SNF5, SNF5 |
Epithelioid Sarcoma; Rhabdomyosarcoma, Corpus; Smooth Muscle Tumors, Vulva |
|
Insulin |
peptide hormone produced in islets of Langerhans in pancreas |
HB125 |
Neuroendocrine Tumors |
|
Ki-67 |
marker of cell proliferation |
MMI, KI88, IVAK-2, MIB1 |
Atypical Nevus of the Genital Tract; Cervical Infections; Clear Cell Adenocarcinoma, Corpus; Endometrial Metaplasias; Endometrial Polyp; Fallopian Tube Metaplasia; Granular Cell Tumor; High-Grade Serous Adenocarcinoma; Immature Squamous Metaplasia, Cervix; Metaplastic Papillary Tumor; Microcystic Adnexal Carcinoma; Ovarian Lymphomas and Leukemias; Pseudocarcinomatous Hyperplasia; Sebaceous Carcinoma; Sebaceous Hyperplasia; Serous Adenocarcinoma, Corpus; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Squamous Intraepithelial Lesion/Dysplasia; Trichoepithelioma; Tunnel Clusters; Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia; Adenocarcinoma In Situ, Including Variants, Cervix; Tunnel Clusters |
|
LCA |
leukocyte common antigen |
PD7/26, 1.22/4.14, T29/33, CD45RB, RP2/18, CD45, PD7, 2D1, 2B11+PD7/26 |
Endometrioid Adenocarcinoma and Variants, Corpus; Small Cell Carcinoma of Ovary, Hypercalcemic Type |
|
LEU-7 |
β-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
CD57, NK1, HNK-1, TB01, B3GAT1 |
Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors |
|
LEU-M1 |
reacts with Reed-Sternberg cells of Hodgkin disease and with granulocytes |
VIM-2, 3C4, CD15, TU9, VIM-D5, MY1, CBD1, MMA, 3CD1, C3D1, Lewis x, SSEA-1 |
Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Sebaceous Carcinoma; Serous Borderline Tumor, Ovary; Serous Carcinoma, Peritoneum |
|
Leukocyte common antigen |
|
LCA, PD7/26, 1.22/4.14, T29/33, CD45RB, RP2/18, CD45, PD7, 2D1, 2B11+PD7/26 |
Intraabdominal Desmoplastic Small Round Cell Tumor |
|
LH |
lutenizing hormone |
beta-LH |
Autoimmune Oophoritis |
|
LIN28 |
zinc finger CCHC domain containing 1 antibody |
Tex17, ZCCHC1, CSDD1, AL024421 |
Dysgerminoma |
|
Lysozyme |
1,4-beta N-acetylmuramidase C |
Lyz, Lzm, Ec3.2.1.17 |
Cervical Infections; Lymphoma and Leukemia, Uterus; Neuroendocrine Tumors; Ovarian Lymphomas and Leukemias |
|
MAGE-A4 |
melanoma antigen family |
Mage-4, 57B |
Dysgerminoma |
|
Mammaglobin |
breast tissue-specific glycoprotein |
304-1A5 |
Endometrioid Adenocarcinoma, Ovary; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic/Secondary Tumors to the Cervix; Sclerosing Stromal Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum |
|
MART-1 |
mart-1 clone of Melan A |
|
Atypical Nevus of the Genital Tract; Dermatofibrosarcoma Protuberans; Dysgerminoma; Extramammary Paget Disease; Malignant Melanoma, Vulva; Metastatic Melanoma; Mucosal Melanotic Macule; Smooth Muscle Tumors, Vulva |
|
mCEA |
carcinoembryonic antigen, monoclonal |
CEA-M, mCEA, CEA-B18, CEA-D14, CEAGOLD 1, T84.6, CEA-GOLD 2, CEA 11, CEA-GOLD 3, CEA 27, CEAGOLD 4, CEA 41, CEA-GOLD 5, T84.1, CEA-M, A5B7, CEJ065, IL-7, T84.66, TF3H8-1, 0062, D14, alpha-7, PARLAM 1, ZC23, CEM010, A115, COL-1, AF4, 12.140.10, 11-7, M773, CEA-M431_31, CEJO65 |
Endometrioid Adenocarcinoma and Variants, Corpus; Pseudomyxoma Peritonei |
|
Mel-5 |
|
|
Atypical Nevus of the Genital Tract |
|
MEL-CAM |
melanoma cell adhesion molecule |
CD146, MN4, MUC18 |
Deciduosis; Leiomyosarcoma; Squamous Cell Carcinoma, Corpus |
|
Melan-A |
melanoma antigen recognized by T cells 1 (MART-1); protein found on melanocytes; melanocyte differentiation antigen |
M2-7C10, CK-MM |
Adenocarcinoma, Clear Cell, Cervix; Alveolar Soft Part Sarcoma; Benign and Low-Grade Endometrial Stromal Tumors; Clear Cell Adenocarcinoma, Corpus; Disseminated Peritoneal Leiomyomatosis; Epithelioid Sarcoma; Extramammary Paget Disease; Hepatoid Carcinoma; Leiomyoma and Variants; Leiomyosarcoma; Leydig Cell Tumor; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Mucosal Melanotic Macule; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Perivascular Epithelioid Cell (PEC) Proliferations; Pregnancy Luteoma; Secondary Neoplasms, Uterus; Sertoli-Leydig Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Smooth Muscle Tumors, Ovary; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Stromal Luteoma; Struma Ovarii; Thecoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors |
|
Mesothelin |
|
5B2 |
Benign Müllerian Lesions; Malignant Mesothelioma, Peritoneum; Metastatic Breast Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Well-Differentiated Papillary Mesothelioma |
|
MIB1 |
marker of cell proliferation |
Ki-67 |
Adenocarcinoma In Situ, Including Variants, Cervix; Arias-Stella Reaction; Atrophy; Deep Glands and Cysts; Ectopic Prostate; Immature Squamous Metaplasia, Cervix; Leiomyoma and Variants; Microglandular Hyperplasia; Müllerian Papilloma; Serous Carcinoma (Including STIC) |
|
Microphthalmia transcription factor |
|
MITF, 34CA5, D5, C5+D5 |
Clear Cell Adenocarcinoma, Corpus |
|
MITF |
microphthalmia transcription factor |
34CA5, D5, C5+D5 |
Alveolar Soft Part Sarcoma; Epithelioid Sarcoma; Extramammary Paget Disease; Leydig Cell Tumor; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Perivascular Epithelioid Cell (PEC) Proliferations; Small Cell Carcinoma of Ovary, Hypercalcemic Type |
|
MLH1 |
mutL homolog 1 |
HMLH1, G168-15, G168-728, MMR family; HNPCC2, COCA2 |
Endometrioid Adenocarcinoma and Variants, Corpus; Sebaceous Carcinoma; Undifferentiated Carcinoma, Corpus |
|
MOC-31 |
lung cancer marker |
|
Adenomatoid Tumor, Corpus; Florid Mesothelial Hyperplasia; Intraabdominal Desmoplastic Small Round Cell Tumor; Malignant Mesothelioma, Peritoneum; Peritoneal Inclusion Cysts; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Well-Differentiated Papillary Mesothelioma |
|
MSA |
muscle-specific actin |
ACTIN-SM, ASM-1, CGA7, 1A4, HUC1-1 |
Intraabdominal Desmoplastic Small Round Cell Tumor |
|
MSH2 |
mutS homolog 2 |
FE11 |
Borderline Clear Cell Adenofibroma; Endometrioid Adenocarcinoma and Variants, Corpus; Sebaceous Carcinoma |
|
MSH6 |
mut S homolog 6 |
clone 44, GRBP.P1, DNA mismatch repair protein MSH6 antibody, G/T mismatch binding protein antibody, GTBP antibody, GTMBP antibody, HNPCC 5 antibody, HNPCC5 antibody, HSAP |
Borderline Clear Cell Adenofibroma; Endometrioid Adenocarcinoma and Variants, Corpus; Sebaceous Carcinoma |
|
MUC1 |
epithelial membrane antigen |
LICR-LON-M8, BC3, DF3, VU3D1, MUSEII, RD-1, MA695, MA552, PS2P446, 115D8 |
Extramammary Paget Disease; Fallopian Tube Metaplasia; Malignant Melanoma, Vulva |
|
MUC2 |
mucin 2, intestinal |
CCP58, MUC2-P, M53, MRP, LUM2-3, LDQ10 |
Extramammary Paget Disease; Malignant Melanoma, Vulva; Pseudomyxoma Peritonei |
|
MUC5 |
mucin 5AC, tracheobronchial, gastric |
CLH2 2, 45M1, MUC5AC, CLH2 |
Extramammary Paget Disease; Malignant Melanoma, Vulva |
|
MUC5AC |
mucin 5AC, tracheobronchial, gastric |
MUC5, CLH2 2, 45M1, MUC5AC, CLH2 |
Extramammary Paget Disease |
|
MUC6 |
mucin 6, gastric |
CLH5 |
Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinomas, Non-Clear Cell Type; Fallopian Tube Metaplasia |
|
Muscle-specific actin |
|
MSA, ACTIN-SM, ASM-1, CGA7, 1A4, HUC1-1 |
Rhabdomyoma; Rhabdomyosarcoma, Cervix |
|
Myeloperoxidase |
|
MPO |
Cervical Infections; Lymphoma and Leukemia, Uterus; Lymphomas and Leukemias of the Lower Genital Tract; Neuroendocrine Tumors; Ovarian Lymphomas and Leukemias |
|
MYF4 |
myogenin |
F5D, MYF3, LO26 |
Intraabdominal Desmoplastic Small Round Cell Tumor |
|
MYOD1 |
myogenic differentiation 1 |
5.8A, 5.2F |
Alveolar Soft Part Sarcoma; Benign and Low-Grade Endometrial Stromal Tumors; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyoma and Variants; Leiomyosarcoma; Malignant Mixed Mesodermal Tumor; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Yolk Sac Tumor, Vagina |
|
Myogenin |
|
MYF4, F5D, MYF3, LO26 |
Benign and Low-Grade Endometrial Stromal Tumors; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Leiomyosarcoma; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Corpus; Müllerian Papilloma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Yolk Sac Tumor, Vagina |
|
Myoglobin |
iron and oxygen-building protein found in muscle tissue |
MG-1 |
Benign and Low-Grade Endometrial Stromal Tumors; Inflammatory Myofibroblastic Tumor; Leiomyosarcoma; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Wilms Tumor; Yolk Sac Tumor, Vagina |
|
Myosin |
motor protein responsible for actinbased motility |
|
Leiomyoma and Variants; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Uterine Tumors Resembling Ovarian Sex Cord Tumors |
|
Myosin heavy chain smooth muscle |
|
SMHC, ID8, SM MYOSIN H, HSM-V, SMMS-1 |
Uterine Tumors Resembling Ovarian Sex Cord Tumors |
|
NANOG |
embryonic stem cell-specific homeobox protein |
AF 1997 |
Dysgerminoma; Yolk Sac Tumor, Ovary |
|
Napsin-A |
napsin A aspartic peptidase |
TMU-AD02 |
Clear Cell Carcinoma, Ovary; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Squamous Cell Carcinoma, Cervix; Struma Ovarii |
|
Nestin |
neural stem cell marker |
10C2 |
Extragastrointestinal Stromal Tumor |
|
NKI/C3 |
tetraspan intracellular granule protein |
CD63, basophil activation test in allergy |
Verruciform Xanthoma |
|
NSE |
neuron specific enolase |
BSS/H14 |
Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Alveolar Soft Part Sarcoma; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Dysgerminoma; Granular Cell Tumor; Immature Teratoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Large Cell Neuroendocrine Carcinoma; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Strumal Carcinoid; Wilms Tumor |
|
NY-ESO-1 |
cancer/testis antigen 1B |
CST6, ES121, CTAG-1B |
Dysgerminoma |
|
OCT4 |
octamer-binding transcription factor-3 |
OCT3, POU5F1 (OCT3/4), C-10 |
Clear Cell Carcinoma, Ovary; Dysgerminoma; Gonadoblastoma; Immature Teratoma; Sertoli Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Yolk Sac Tumor, Ovary |
|
Oxytocin |
|
OTR, oxytocin RE |
Leiomyoma and Variants |
|
P-cadherin |
placental dependant adhesion protein |
clone 56 |
Malignant Mixed Müllerian Tumor, Corpus |
|
p16 |
cyclin dependent kinase 4 inhibitor A |
Cyclin dependent kinase inhibitor p16 antibody, INK4, INK4a, MLM, MTS1, multiple tumor suppressor 1 antibody, p12, p14, p16 γ, p16 INK4, p16 INK4a, INK4 p19, TP16, P16_INK4A, E6H4, sc1661, JC8, ZJ11, G175-405, F-12, DCS-50, 6H12, 16P07, 16P04 |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenocarcinoma, Villoglandular; Adenoid Basal Carcinoma; Adenosquamous Carcinoma Including Glassy Cell Carcinoma; Atrophy; Bartholin Gland Carcinoma; Basal Cell Carcinoma; Benign Müllerian Lesions; Cellular Angiofibroma; Clear Cell Adenocarcinoma, Corpus; Ectopic Prostate; Endocervical Polyp; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Endometriosis, Cervix; Extramammary Paget Disease; Fibromatous Neoplasms; High-Grade Serous Adenocarcinoma; Immature Squamous Metaplasia, Cervix; Leiomyoma and Variants; Leiomyosarcoma; Lichen Sclerosus; Low-Grade Serous Adenocarcinoma; Lymphomas and Leukemias of the Lower Genital Tract; Malignant Brenner Tumor; Malignant Melanoma, Vulva; Malignant Mesothelioma, Peritoneum; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Mesonephric Adenocarcinoma; Mesonephric Remnants/Hyperplasia; Metastatic Cervical Carcinoma; Metastatic Pancreaticobiliary Adenocarcinoma; Metastatic/Secondary Tumors to the Cervix; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Nongestational Choriocarcinoma; Proliferating/Borderline Brenner Tumor; Pseudocarcinomatous Hyperplasia; Sebaceous Carcinoma; Secondary Neoplasms, Uterus; Secondary Tumors in Teratomas; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Corpus; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Squamous Intraepithelial Lesion/Dysplasia; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Transitional Cell Metaplasia; Tubal and Tuboendometrioid Metaplasia; Tunnel Clusters; Vaginal Intraepithelial Neoplasia; Vulvar Intraepithelial Neoplasia |
|
p40 |
p40 tax antibody |
HTLV-1 |
Metastatic Lung Carcinoma |
|
p53 |
p53 tumor suppressor gene protein |
DO7, 21N, BP53-12-1, AB6, CM1, PAB1801, DO1, BP53-11, PAB240, RSP53, MU195, PAB1801, nuclear p53, P53 |
Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenoid Basal Carcinoma; Basal Cell Carcinoma; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Fallopian Tube Metaplasia; Florid Mesothelial Hyperplasia; Granular Cell Tumor; High-Grade Serous Adenocarcinoma; Leiomyoma and Variants; Leiomyosarcoma; Lichen Sclerosus; Low-Grade Serous Adenocarcinoma; Malignant Brenner Tumor; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Corpus; Metaplastic Papillary Tumor; Metastatic Uterine Corpus Carcinoma to Ovary; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Proliferating/Borderline Brenner Tumor; Pseudocarcinomatous Hyperplasia; Salpingitis; Sebaceous Carcinoma; Sebaceous Hyperplasia; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Squamous Intraepithelial Lesion/Dysplasia; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Undifferentiated Uterine Sarcoma; Vulvar Intraepithelial Neoplasia |
|
p63 |
tumor protein p63 |
P63-P53 homologous nuclear protein; DELTA-NP63, 4A4, P63, H-137, 7JUL |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenoid Basal Carcinoma; Adenosquamous Carcinoma Including Glassy Cell Carcinoma; Benign Brenner Tumor; Benign Müllerian Lesions; Eccrine Spiradenoma; Ectopic Prostate; Endometrioid Adenocarcinoma and Variants, Corpus; Epithelioid Sarcoma; Fallopian Tube Metaplasia; Hidradenoma Papilliferum; Immature Squamous Metaplasia, Cervix; Leiomyosarcoma; Malignant Melanoma, Vulva; Metastatic Cervical Carcinoma; Metastatic Lung Carcinoma; Microcystic Adnexal Carcinoma; Microglandular Hyperplasia; Mixed Tumor, Vulva; Mucinous Borderline Tumor, Endocervical Type; Neuroendocrine Tumors; Nongestational Choriocarcinoma; Proliferating/Borderline Brenner Tumor; Sebaceous Carcinoma; Secondary Neoplasms, Vagina; Squamous Cell Carcinoma, Cervix; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Squamous Intraepithelial Lesion/Dysplasia; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Transitional Cell Metaplasia; Vulvar Intraepithelial Neoplasia |
|
p504S |
alpha-methylacyl-CoA racemase (AMACR) |
13H4, AMACR |
Metastatic Colorectal Carcinoma |
|
p75 |
|
|
Malignant Melanoma, Vulva |
|
Pan keratin |
cytokeratin-pan (AE1/AE3/LP34); cocktail of high and low molecular weight cytokeratins |
keratin pan, MAK-6, K576, LU-5, KL-1, KC-8, MNF 116, pankeratin, pancytokeratin |
Benign Müllerian Lesions; Hepatoid Carcinoma |
|
Pancytokeratin |
cytokeratin-pan (AE1/AE3/LP34); cocktail of high and low molecular weight cytokeratins |
keratin pan, MAK-6, K576, LU-5, KL-1, KC-8, MNF 116, pankeratin, pan keratin |
Malignant Mesothelioma, Peritoneum |
|
PAP |
prostatic acid phosphatase |
PASE/4LJ, PAP-P |
Polyps |
|
pax-2 |
paired box gene 2 |
Z-RX2, PAX-2 |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Endometrioid, Cervix; Deep Glands and Cysts; Endocervicosis; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometriosis, Cervix; Low-Grade Serous Adenocarcinoma; Malignant Mesothelioma, Peritoneum; Mesonephric Remnants/Hyperplasia; Müllerian Papilloma; Serous Carcinoma, Peritoneum; Tubal and Tuboendometrioid Metaplasia; Tunnel Clusters |
|
pax-8 |
paired box gene 8 |
|
Adenomatoid Tumor, Corpus; Alveolar Soft Part Sarcoma; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Clear Cell Carcinoma, Ovary; Deep Glands and Cysts; Dysgerminoma; Endocervicosis; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Female Adnexal Tumor of Probable Wolffian Origin; Florid Mesothelial Hyperplasia; Germ Cell Tumors, Uterus; High-Grade Serous Adenocarcinoma; Low-Grade Serous Adenocarcinoma; Malignant Brenner Tumor; Malignant Mesothelioma, Peritoneum; Mesonephric Adenocarcinoma; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Metastatic/Secondary Tumors to the Cervix; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Peritoneal Inclusion Cysts; Proliferating/Borderline Brenner Tumor; Secondary Neoplasms, Uterus; Secondary Neoplasms, Vagina; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Sertoli Cell Tumor; Stromal Luteoma; Struma Ovarii; Strumal Carcinoid; Well-Differentiated Papillary Mesothelioma; Yolk Sac Tumor, Ovary |
|
pCEA |
carcinoembryonic antigen, polyclonal |
|
Hepatoid Carcinoma; Pseudomyxoma Peritonei |
|
Perilipin |
|
|
Extramammary Paget Disease |
|
PHLDA1 |
|
|
Trichoepithelioma |
|
PKC-θ |
protein kinase C theta |
Clone 27, PKC-Theta |
Ovarian Involvement by Gastrointestinal Stromal Tumor |
|
PLAP |
placental alkaline phosphatase |
228M, 8A9, 88B |
Dysgerminoma; Sertoli Cell Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Squamous Intraepithelial Lesion/Dysplasia; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor |
|
PMS2 |
|
|
Endometrioid Adenocarcinoma and Variants, Corpus; Undifferentiated Carcinoma, Corpus |
|
Podoplanin |
transmembrane mucoprotein (38 kd) recognized by the D2-40 monoclonal antibody |
D2-40, M2A |
Eccrine Spiradenoma; Florid Mesothelial Hyperplasia; Gonadoblastoma; Malignant Mesothelioma, Peritoneum; Microcystic Adnexal Carcinoma; Peritoneal Inclusion Cysts |
|
POU5F1 |
octamer-binding transcription factor- |
OCT3, OCT4, C-10 |
Gonadoblastoma |
|
PR |
progesterone receptor protein |
PRP, 10A9, PGR-1A6, KD68, PGR-ICA, PRP-P, PRI, 1A6, 1AR, HPRA3, PGR-636, 636, PR88, NCL-PGR |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Clear Cell, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Gastric and Intestinal Types Including Signet Ring Cell Carcinoma; Adenocarcinoma, Minimal Deviation; Adenocarcinoma, Serous, Cervix; Adenocarcinoma, Usual Type; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Polypoid Adenomyoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Deep Aggressive Angiomyxoma; Disseminated Peritoneal Leiomyomatosis; Endocervicosis; Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Fallopian Tube; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Endometriosis and Deciduosis; Endometriosis, Cervix; Extragastrointestinal Stromal Tumor; Extramammary Paget Disease; Fibroadenoma and Phyllodes Tumor; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Hepatoid Carcinoma; Hidradenoma Papilliferum; High-Grade Endometrial Stromal Sarcoma; High-Grade Serous Adenocarcinoma; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Low-Grade Serous Adenocarcinoma; Luteinized Thecoma With Sclerosing Peritonitis; Lymphoma and Leukemia, Uterus; Malignant Mesothelioma, Peritoneum; Malignant Mixed Müllerian Tumor, Corpus; Mesodermal Adenosarcoma; Mesonephric Adenocarcinoma; Metastatic Breast Carcinoma; Metastatic/Secondary Tumors to the Cervix; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Cystadenoma/Adenofibroma/Cystadenofibroma; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Rhabdomyoma; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Secondary Neoplasms, Uterus; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma, Peritoneum; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma, Pulmonary Type; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Squamous Cell Carcinoma, Corpus; Stromal Luteoma; Syringoma; Thecoma; Tubal and Tuboendometrioid Metaplasia; Undifferentiated Carcinoma, Corpus; Undifferentiated Uterine Sarcoma; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Wilms Tumor; Yolk Sac Tumor, Vagina |
|
ProEx C |
cocktail of monoclonal antibodies against proteins associated with aberrant S-phase cell cycle induction (topoisomerase IIA, minichromosome maintenance protein 2) |
|
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Usual Type; Atrophy; Microglandular Hyperplasia; Tubal and Tuboendometrioid Metaplasia; Endometrioid Adenocarcinoma and Variants, Corpus |
|
Progesterone receptor |
|
PR, PRP, 10A9, PGR-1A6, KD68, PGRICA, PRP-P, PRI, 1A6, 1AR, HPRA3, PGR-636, 636, PR88, NCL-PGR |
Fibroepithelial Stromal Polyp; Mixed Tumor, Vagina; Polyps |
|
Prostate stem cell antigen |
|
PSCA, 1G8 |
Metastatic Pancreaticobiliary Adenocarcinoma |
|
PSA |
prostate specific antigen |
ER-PR8, PSA-P, F5 |
Ectopic Prostate; Polyps |
|
PSAP |
prostatic acid phosphatase |
PAP, PASE/4LJ, PAP-P |
Ectopic Prostate; |
|
PTAH |
|
|
Rhabdomyoma; Rhabdomyosarcoma, Corpus |
|
PTEN |
phosphatase and tensin homolog |
PN37 |
Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia |
|
RCC |
renal cell carcinoma |
66.4C2, PN-15, RCC, RCC MA |
Alveolar Soft Part Sarcoma; Müllerian Papilloma; Secondary Neoplasms, Vagina; Struma Ovarii |
|
S100 |
low molecular weight protein normally present in cells derived from neural crest (Schwann cells, melanocytes, and glial cells), chondrocytes, adipocytes, myoepithelial cells, macrophages, Langerhans cells, dendritic cells, and keratinocytes |
S-100, A6, 15E2E2, Z311, 4C4.9, S100 protein |
Adenocarcinoma, Clear Cell, Cervix; Adenoid Cystic Carcinoma; Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Angiomyofibroblastoma; Atypical Nevus of the Genital Tract; Cellular Angiofibroma; Deep Aggressive Angiomyxoma; Dermatofibrosarcoma Protuberans; Dysgerminoma; Epithelioid Sarcoma; Extragastrointestinal Stromal Tumor; Extramammary Paget Disease; Granular Cell Tumor; Hepatoid Carcinoma; Hidradenoma Papilliferum; Immature Teratoma; Inflammatory Myofibroblastic Tumor; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Leiomyosarcoma; Lymphomas and Leukemias of the Lower Genital Tract; Malakoplakia; Malignant Melanoma, Vagina; Malignant Melanoma, Vulva; Melanoma; Metastatic Lung Carcinoma; Metastatic Melanoma; Mixed Tumor, Vagina; Mixed Tumor, Vulva; Ovarian Involvement by Gastrointestinal Stromal Tumor; Perivascular Epithelioid Cell (PEC) Proliferations; Prepubertal Vulval Fibroma; Primitive Neuroectodermal Tumor, Ovary; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyoma; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Secondary Neoplasms, Uterus; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Smooth Muscle Tumors, Vulva; Solitary Fibrous Tumor, Peritoneum; Solitary Fibrous Tumor, Vulva; Squamous Cell Carcinoma, Vagina; Squamous Cell Carcinoma, Vulva; Steroid Cell Tumor, Not Otherwise Specified; Struma Ovarii; Superficial Angiomyxoma; Undifferentiated Carcinoma, Corpus; Verruciform Xanthoma |
|
SALL4 |
sal-like protein 4 |
|
Borderline Clear Cell Adenofibroma; Clear Cell Carcinoma, Ovary; Dysgerminoma; Endometrioid Adenocarcinoma, Ovary; Germ Cell Tumors, Uterus; Gonadoblastoma; Hepatoid Carcinoma; Immature Teratoma; Juvenile Granulosa Cell Tumor; Metastatic Melanoma; Microcystic Stromal Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Yolk Sac Tumor, Ovary; Yolk Sac Tumor, Vagina |
|
Serotonin |
5-hydroxytryptamine (5-HT), a monoamine neurotransmitter |
5-HT, 5HT-H209 |
Benign Brenner Tumor; Neuroendocrine Tumors; Strumal Carcinoid; Transitional Cell Metaplasia |
|
SF1 |
steroidogenic factor-1 |
AD4BP |
Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endometrioid Adenocarcinoma, Ovary; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Gonadoblastoma; Hepatoid Carcinoma; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Leydig Cell Tumor; Luteinized Thecoma With Sclerosing Peritonitis; Metastatic Appendiceal Tumors; Metastatic Melanoma; Serous Borderline Tumor, Ovary; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord-Stromal Tumor, Not Otherwise Specified; Steroid Cell Tumor, Not Otherwise Specified; Struma Ovarii; Strumal Carcinoid; Transitional Cell Carcinoma (Non-Brenner Type); Unclassified Mixed Germ Cell/Sex Cord-Stromal Tumor; Yolk Sac Tumor, Ovary |
|
SMA |
actin, smooth muscle |
Actin-sm, ASM-1, CGA7, 1A4, HUC1-1 |
Adult Granulosa Cell Tumor; Alveolar Soft Part Sarcoma; Extragastrointestinal Stromal Tumor; Fibromatous Neoplasms; Luteinized Thecoma With Sclerosing Peritonitis; Thecoma |
|
SMA-α |
actin, smooth muscle, alpha |
|
Hidradenoma Papilliferum |
|
SMAD4 |
Similar to mothers against decapentaplegic (MAD); mothers against DPP homolog 4 |
MADR1 JV4-1, DPC4_SMAD4, B-8 |
Metastatic Pancreaticobiliary Adenocarcinoma; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Intestinal Type; Secondary Neoplasms, Uterus |
|
SMARCB1 |
|
|
Epithelioid Sarcoma |
|
Smooth muscle actin |
|
SMA, Actin-sm, ASM-1, CGA7, 1A4, HUC1-1 |
Angiomyofibroblastoma; Disseminated Peritoneal Leiomyomatosis; Endocervical-Type Adenomyoma; Fibroepithelial Stromal Polyp; Inflammatory Myofibroblastic Tumor; Intravenous Leiomyomatosis; Leiomyoma and Variants; Leiomyosarcoma; Massive Vulval Edema; Mesodermal Adenosarcoma; Mixed Tumor, Vagina; Müllerian Adenosarcoma, Cervix; Perivascular Epithelioid Cell (PEC) Proliferations; Prepubertal Vulval Fibroma; Rhabdomyosarcoma, Corpus; Sclerosing Stromal Tumor; Smooth Muscle Tumors, Ovary; Smooth Muscle Tumors, Vulva; Superficial Angiomyxoma |
|
Smoothelin |
cytoskeletal protein specific for smooth muscle cells |
|
Extragastrointestinal Stromal Tumor |
|
Somatostatin |
|
|
Neuroendocrine Tumors |
|
SOX2 |
SRY (sex-determining region Y)-box 2 protein |
SOX2 (AB5603) |
Dysgerminoma; Yolk Sac Tumor, Ovary |
|
SOX10 |
SRY (sex-determining region Y)-box 10 protein |
|
Epithelioid Sarcoma; Malignant Melanoma, Vulva; Melanoma |
|
Survivin |
inhibitor of apoptosis |
AB469, SURVIVIN, FL-142, D8, 8E12 |
Sebaceous Hyperplasia |
|
Synaptophysin |
major synaptic vesicle protein p38 antibody |
SVP38, SY38, SNP-88, SYP, SYPH, Sypl, Syn p38 |
Adenoid Basal Carcinoma; Adenoid Cystic Carcinoma; Adult Granulosa Cell Tumor; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Endometrioid Adenocarcinoma, Ovary; Hepatoid Carcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Juvenile Granulosa Cell Tumor; Large Cell Neuroendocrine Carcinoma; Malignant Mixed Mesodermal Tumor; Metastatic Appendiceal Tumors; Metastatic Breast Carcinoma; Metastatic Gastric Carcinoma; Metastatic Lung Carcinoma; Neuroendocrine Carcinomas, Corpus; Neuroendocrine Tumors; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Rhabdomyosarcoma, Corpus; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Squamous Cell Carcinoma, Cervix; Struma Ovarii; Strumal Carcinoid; Undifferentiated Carcinoma, Corpus |
|
Syndecan |
useful marker for plasma cells |
CD138, B-B4, AM411-10M, MI15 |
Endometritis |
|
TAG72 |
tumor-associated glycoprotein-72 |
CC49, B72.3, BRST-3 |
Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum |
|
TdT |
terminal deoxynucleotidyl transferase |
SEN 28 |
Lymphomas and Leukemias of the Lower Genital Tract |
|
TFE3 |
transcription factor E3 |
|
Alveolar Soft Part Sarcoma; Clear Cell Adenocarcinoma, Corpus; Perivascular Epithelioid Cell (PEC) Proliferations; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus |
|
Thrombomodulin |
|
1009,15C8 |
Adenomatoid Tumor, Corpus; Benign Brenner Tumor; Florid Mesothelial Hyperplasia; Malignant Mesothelioma, Peritoneum; Proliferating/Borderline Brenner Tumor; Serous Carcinoma, Peritoneum; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube |
|
Thyroglobulin |
dimetric protein specific to thyroid gland |
DAK-TG6 |
Benign Serous Tumors, Ovary; Carcinoid Tumor (Insular, Trabecular, and Mucinous); Microcystic Stromal Tumor; Struma Ovarii; Strumal Carcinoid |
|
TLE1 |
transducer like enhancer 1 |
|
Dermatofibrosarcoma Protuberans; Extragastrointestinal Stromal Tumor; Pseudomyxoma Peritonei; Solitary Fibrous Tumor, Peritoneum |
|
TNF-α |
cytokine involved in systemic inflammation, stimulates the acute phase reaction |
Gamma catenin, γ-catenin, G-catenin, alpha alpha, TNF, cachexin, cachectin |
Fixed Drug Eruption |
|
TSPY |
testis-specific protein, Y-encoded |
|
Dysgerminoma |
|
TTF-1 |
transcription termination factor |
8G7G3/1, SPT-24, SC-13040 |
Borderline Clear Cell Adenofibroma; Leiomyoma and Variants; Malignant Mesothelioma, Peritoneum; Metastatic Lung Carcinoma; Microcystic Stromal Tumor; Neuroendocrine Tumors; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Strumal Carcinoid |
|
Tyrosinase |
catalyzes production of melanin |
NCL-TYROS, T311 |
Extramammary Paget Disease; Malignant Melanoma, Vulva; Melanoma; Metastatic Melanoma |
|
UP3 |
uroplakin-3 |
UP III, AU 1 |
Benign Brenner Tumor |
|
Uroplakin-3 |
|
UP3, UP III, AU 1 |
Benign Brenner Tumor; Extramammary Paget Disease; Malignant Melanoma, Vulva; Proliferating/Borderline Brenner Tumor; Secondary Neoplasms, Vagina; Serous Carcinoma, Peritoneum; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube |
|
Villin |
|
1D2C3 |
Endometrioid Adenocarcinoma and Variants, Corpus |
|
Vimentin |
major subunit protein of intermediate filaments of mesenchymal cells |
43BE8, 3B4, V10, V9, VIM-B34, VIM |
Adenocarcinoma In Situ, Including Variants, Cervix; Adenocarcinoma, Endometrioid, Cervix; Adenocarcinoma, Usual Type; Alveolar Soft Part Sarcoma; Benign and Low-Grade Endometrial Stromal Tumors; Benign Müllerian Lesions; Endometrial Metaplasias; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Fibroadenoma and Phyllodes Tumor; Fibroepithelial Stromal Polyp; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; High-Grade Serous Adenocarcinoma; Leydig Cell Tumor; Malignant Mixed Mesodermal Tumor; Malignant Mixed Müllerian Tumor, Cervix; Malignant Mixed Müllerian Tumor, Corpus; Mesonephric Adenocarcinoma; Metastatic Lung Carcinoma; Metastatic/Secondary Tumors to the Cervix; Microcystic Stromal Tumor; Microglandular Hyperplasia; Mucinous Adenocarcinoma, Corpus; Mucinous Adenocarcinoma, Ovary; Mucinous Cystic Tumor with Mural Nodules; Müllerian Papilloma; Peritoneal Inclusion Cysts; Polyps; Primitive Neuroectodermal Tumor, Peripheral and Central Types; Sclerosing Stromal Tumor; Secondary Neoplasms, Uterus; Sertoli Cell Tumor; Signet Ring Cell Stromal Tumor; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Solitary Fibrous Tumor, Peritoneum; Superficial Angiomyxoma; Tubal and Tuboendometrioid Metaplasia |
|
WT1 |
Wilms tumor gene-01 |
6F-H2, C-19, WT1 |
Adenocarcinoma, Serous, Cervix; Adenomatoid Tumor, Corpus; Adenomatoid Tumor, Fallopian Tube; Adult Granulosa Cell Tumor; Benign and Low-Grade Endometrial Stromal Tumors; Benign Brenner Tumor; Benign Müllerian Lesions; Benign Serous Tumors, Ovary; Borderline Clear Cell Adenofibroma; Clear Cell Adenocarcinoma, Corpus; Clear Cell Carcinoma, Ovary; Endometrioid Adenocarcinoma and Variants, Corpus; Endometrioid Adenocarcinoma, Ovary; Endometrioid Adenofibroma/Cystadenofibroma; Endometrioid Borderline Tumor; Extragastrointestinal Stromal Tumor; Female Adnexal Tumor of Probable Wolffian Origin; Fibromatous Neoplasms; Florid Mesothelial Hyperplasia; Hepatoid Carcinoma; High-Grade Serous Adenocarcinoma; Intraabdominal Desmoplastic Small Round Cell Tumor; Intravenous Leiomyomatosis; Juvenile Granulosa Cell Tumor; Leiomyosarcoma; Leydig Cell Tumor; Low-Grade Serous Adenocarcinoma; Lymphoma and Leukemia, Uterus; Malignant Brenner Tumor; Malignant Mesothelioma, Ovary; Malignant Mesothelioma, Peritoneum; Mesodermal Adenosarcoma; Metastatic Breast Carcinoma; Metastatic Lung Carcinoma; Metastatic Uterine Corpus Carcinoma to Ovary; Mucinous Adenocarcinoma, Ovary; Mucinous Borderline Tumor, Endocervical Type; Mucinous Borderline Tumor, Intestinal Type; Müllerian Adenosarcoma, Cervix; Ovarian Endometrioid Stromal Sarcoma, Low Grade; Peritoneal Inclusion Cysts; Perivascular Epithelioid Cell (PEC) Proliferations; Proliferating/Borderline Brenner Tumor; Rhabdomyosarcoma, Cervix; Rhabdomyosarcoma, Corpus; Serous Adenocarcinoma, Corpus; Serous Borderline Tumor, Fallopian Tube; Serous Borderline Tumor, Ovary; Serous Borderline Tumor, Peritoneum; Serous Carcinoma (Including STIC); Serous Carcinoma, Peritoneum; Sertoli Cell Tumor; Sertoli-Leydig Cell Tumor; Sex Cord Tumor With Annular Tubules; Small Cell Carcinoma of Ovary, Hypercalcemic Type; Small Cell Carcinoma, Pulmonary Type; Struma Ovarii; Thecoma; Transitional Cell Carcinoma (Non-Brenner Type); Transitional Cell Carcinoma, Fallopian Tube; Uterine Tumors Resembling Ovarian Sex Cord Tumors; Well-Differentiated Papillary Mesothelioma; Wilms Tumor | |
